• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Table 13External validation studies of PROCAM risk scoring methods

Type of study Location First author)Name of cohortPROCAM methodSpecific inclusion criteriaGenderAgeStart date of recruitmentNotes
Community studies
UK, Chambers 2001245West LondonUnspecified100% men35–601995–1998Comparison of cross-sectional survey with contemporary incidence data
Italy, Ferrario 200537CUORE cohorts project. 11 of 17 Italian cohorts10-year Assmann 2002100% men35–691983–1996Longitudinal Limited data
Combined community and occupational studies
Northern Ireland, Empana 2003250PRIME, Northern Ireland10-year Assmann 2002100% men50–591991–1993Logitudinal
Occupational studies
France, Empana 2003250PRIME, France10-year Assmann 2002100% men50–591991–1993Logitudinal
Specific patient groups
Germany, Schulz 200325710-year Assmann 2002Patients with CHD negative coronary angiography100% menMean age 531992Logitudinal
Randomised controlled trials
Finland, Assmann 1990146Helsinki Heart StudyAssmann 1990Asymptomatic primary dyslipidaemia; gemfibrozil100% men40–551973-Logitudinal
Finland, Assmann 1990146Helsinki Heart StudyAssmann 1990Asymptomatic primary dyslipidaemia: controls100% men40–551973-Logitudinal

From: External validation of cardiovascular risk scores to evaluate the generalisability of risk scoring methods in different populations

Cover of A Systematic Review of Risk Scoring Methods and Clinical Decision Aids Used in the Primary Prevention of Coronary Heart Disease (Supplement)
A Systematic Review of Risk Scoring Methods and Clinical Decision Aids Used in the Primary Prevention of Coronary Heart Disease (Supplement) [Internet].
NICE Clinical Guidelines, No. 67S.
Beswick AD, Brindle P, Fahey T, et al.
Copyright © 2008, Royal College of General Practitioners.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.